Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
The hypotheses of this study were that:

 1. HIV lipodystrophy is associated with psychological morbidity relating to body image,
 anxiety and depression.

 2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or
 Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical
 volume of treated areas.

 3. The DI3D system is a valid and reproducible method of recording and measuring facial 3-D
 volume.
as above
Inclusion Criteria:

 -  HIV facial lipoatrophy

 -  concurrent antiretrovirals

 Exclusion Criteria:

 -  known psychological disorder

 -  skin allergies

 -  significant medical problems precluding anaesthesia